skip to primary navigationskip to content

Drug Discovery and Development (3D) Workshop

This Pfizer 3D game enables all participants to collaborate throughout a computer simulated drug development process from pre-clinical research through to final product approval from the FDA.
When Jul 11, 2018
from 11:00 AM to 04:00 PM
Where Seminar Room B, First Floor 17 Mill Lane, Cambridge, CB2 1RX
Add event to calendar vCal

Attendance is free but strictly limited to 25 participants – please register with to reserve your place.

Participants work as an industrial project team, trying to get a great drug to patients. This workshop is a tailored version of a training system that is regularly provided to senior Pfizer R&D scientists and project team leaders.

The facilitator will guide the interactive session using a computer programme simulating the entire spectrum of R&D process based decisions (from target selection, in vivo & safety studies, IND filing, to clinical trial strategy and regulatory interactions).

During the game, your team will encounter decision points and then work together and engage in debate on how to move forward. These decisions will be influenced by data and test results produced by the simulation.

Your decisions and the related outcomes will affect overall quality and competitiveness of your program as reflected by R&D cost, patent/product life and time to market.

About the speaker: Nick leads Pfizer’s UK Academic interactions with the academic & medical institutions of the UK in identifying potential collaborations in the areas of biological space of interest to Pfizer’s Research Units.

This includes overseeing the formation of Innovative Target Exploration Networks (ITEN) of investigators to identify and validate targets including academic medical institutions such as the University of Cambridge.

Nick has a wide breadth of experience across the preclinical and clinical phase of drug discovery and development and in a variety of therapeutic areas including allergy, respiratory, inflammation and rare disease.

Nick has over 20 years’ pharmaceutical and 5 years’ academic experience and obtained his PhD in Anatomical Neuropharmacology at the University of Oxford in 1997 following his Bachelor’s degree in Pharmacology.

Who Should Participate: Researchers and academics who are interested in developing a deep appreciation of the decision processes, cost and timeline for new drug R&D; hands on experience in the drug R&D is preferred but not a must.

Register for the event: This workshop is free to attend and 25 places are available. Places will be filled on a first come-first served basis. Please email Dr Ruchi Chauhan from the Cambridge Academy of Therapeutic Sciences at to reserve your place.

OPdA Tweets

RSS Feed Latest news

University launches Rental Deposit Loan Scheme

Nov 08, 2018

To improve support to staff and assist both recruitment and retention, the University has introduced a new rental deposit loan scheme for all current and prospective members of staff.

Join the Committee for Shaping Horizons 2019 - Fostering Diplomacy through Science and Technology: apply by 11 November

Nov 02, 2018

Shaping Horizons 2019 is a novel science-entrepreneurship diplomacy initiative and will be the first of a series of biennial summits with the ambitious purpose of bringing together leaders from two different regions of the world to discuss pressing challenges and promote diplomatic ties.

Free places for postdocs at the Genomics! Venture Creation Weekend

Oct 16, 2018

15 free places at the Genomics! Venture Creation Weekend (16-18 November, at Cambridge Judge Business School) are available to Cambridge postdocs through the OPdA and p2i network.

View all news